HK1040201A1 - 包含性激素和環糊精的鼻用噴霧溶液的製備方法 - Google Patents
包含性激素和環糊精的鼻用噴霧溶液的製備方法 Download PDFInfo
- Publication number
- HK1040201A1 HK1040201A1 HK02102010.0A HK02102010A HK1040201A1 HK 1040201 A1 HK1040201 A1 HK 1040201A1 HK 02102010 A HK02102010 A HK 02102010A HK 1040201 A1 HK1040201 A1 HK 1040201A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- solution
- cyclodextrin
- estradiol
- process according
- hormone
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Otolaryngology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9812836A FR2784584B1 (fr) | 1998-10-14 | 1998-10-14 | Procede de preparation d'une solution pour pulverisation nasale contenant une ou plusieurs hormones sexuelles et une cyclodextrine |
| FR98/12836 | 1998-10-14 | ||
| PCT/FR1999/002480 WO2000021503A1 (fr) | 1998-10-14 | 1999-10-13 | Procede de preparation d'une solution pour pulverisation nasale contenant une ou plusieurs hormones sexuelles et une cyclodextrine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1040201A1 true HK1040201A1 (zh) | 2002-05-31 |
Family
ID=9531516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK02102010.0A HK1040201A1 (zh) | 1998-10-14 | 1999-10-13 | 包含性激素和環糊精的鼻用噴霧溶液的製備方法 |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1121100B1 (enExample) |
| JP (1) | JP3911125B2 (enExample) |
| KR (1) | KR100462441B1 (enExample) |
| CN (1) | CN1323198A (enExample) |
| AT (1) | ATE237310T1 (enExample) |
| AU (1) | AU756441B2 (enExample) |
| BR (1) | BR9914532A (enExample) |
| CA (1) | CA2346567C (enExample) |
| DE (1) | DE69907005T2 (enExample) |
| DK (1) | DK1121100T3 (enExample) |
| EA (1) | EA003069B1 (enExample) |
| ES (1) | ES2197672T3 (enExample) |
| FR (1) | FR2784584B1 (enExample) |
| HK (1) | HK1040201A1 (enExample) |
| HU (1) | HUP0103968A3 (enExample) |
| NO (1) | NO20011673L (enExample) |
| NZ (1) | NZ510776A (enExample) |
| PL (1) | PL347322A1 (enExample) |
| PT (1) | PT1121100E (enExample) |
| WO (1) | WO2000021503A1 (enExample) |
| ZA (1) | ZA200102961B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2827516B1 (fr) * | 2001-07-19 | 2003-09-19 | Servier Lab | Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone |
| WO2005018607A1 (ja) * | 2003-08-20 | 2005-03-03 | Ajinomoto Co., Inc. | 溶解性を改善した医薬品製剤 |
| GB2482868A (en) * | 2010-08-16 | 2012-02-22 | Franciscus Wilhelmus Henricus Maria Merkus | A testosterone liquid spray formulation for oromucosal administration |
| WO2013052849A2 (en) * | 2011-10-07 | 2013-04-11 | Florida State University Research Foundation | Prophylactic and post-acute use of progesterone to better outcomes associated with concussion |
| WO2013107515A1 (en) | 2012-01-20 | 2013-07-25 | Okapi Sciences Nv | Eye drop composition |
| RU2753511C2 (ru) * | 2017-05-31 | 2021-08-17 | Аратана Терапьютикс, Инк. | Композиция глазных капель |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8801670A (nl) * | 1988-07-01 | 1990-02-01 | Walter Adrianus Josephus Johan | Farmaceutisch preparaat. |
| US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| GB9012663D0 (en) * | 1990-06-07 | 1990-08-01 | Erba Carlo Spa | Galenic formulations containing cyclodextrins |
| DE4207922A1 (de) * | 1992-03-13 | 1993-09-23 | Pharmatech Gmbh | Wasserloesliche einschlussverbindungen und verfahren zu deren herstellung |
| BE1007402A5 (nl) * | 1993-03-26 | 1995-06-06 | Adir | Nasale farmaceutische preparaten met progestagene stof. |
-
1998
- 1998-10-14 FR FR9812836A patent/FR2784584B1/fr not_active Expired - Fee Related
-
1999
- 1999-10-13 DE DE69907005T patent/DE69907005T2/de not_active Expired - Fee Related
- 1999-10-13 KR KR10-2001-7004679A patent/KR100462441B1/ko not_active Expired - Fee Related
- 1999-10-13 EP EP99947567A patent/EP1121100B1/fr not_active Expired - Lifetime
- 1999-10-13 EA EA200100316A patent/EA003069B1/ru not_active IP Right Cessation
- 1999-10-13 HK HK02102010.0A patent/HK1040201A1/zh unknown
- 1999-10-13 DK DK99947567T patent/DK1121100T3/da active
- 1999-10-13 HU HU0103968A patent/HUP0103968A3/hu unknown
- 1999-10-13 AU AU60967/99A patent/AU756441B2/en not_active Ceased
- 1999-10-13 AT AT99947567T patent/ATE237310T1/de not_active IP Right Cessation
- 1999-10-13 CN CN99812123A patent/CN1323198A/zh active Pending
- 1999-10-13 PT PT99947567T patent/PT1121100E/pt unknown
- 1999-10-13 PL PL99347322A patent/PL347322A1/xx unknown
- 1999-10-13 NZ NZ510776A patent/NZ510776A/xx unknown
- 1999-10-13 CA CA002346567A patent/CA2346567C/fr not_active Expired - Fee Related
- 1999-10-13 WO PCT/FR1999/002480 patent/WO2000021503A1/fr not_active Ceased
- 1999-10-13 ES ES99947567T patent/ES2197672T3/es not_active Expired - Lifetime
- 1999-10-13 JP JP2000575479A patent/JP3911125B2/ja not_active Expired - Fee Related
- 1999-10-13 BR BR9914532-4A patent/BR9914532A/pt not_active Application Discontinuation
-
2001
- 2001-04-03 NO NO20011673A patent/NO20011673L/no not_active Application Discontinuation
- 2001-04-10 ZA ZA200102961A patent/ZA200102961B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0103968A3 (en) | 2002-06-28 |
| FR2784584B1 (fr) | 2002-09-20 |
| FR2784584A1 (fr) | 2000-04-21 |
| CA2346567A1 (fr) | 2000-04-20 |
| ZA200102961B (en) | 2001-11-20 |
| NZ510776A (en) | 2002-10-25 |
| NO20011673D0 (no) | 2001-04-03 |
| PT1121100E (pt) | 2003-07-31 |
| ATE237310T1 (de) | 2003-05-15 |
| DE69907005D1 (de) | 2003-05-22 |
| JP2002527374A (ja) | 2002-08-27 |
| KR100462441B1 (ko) | 2004-12-17 |
| KR20010073214A (ko) | 2001-07-31 |
| EA003069B1 (ru) | 2002-12-26 |
| CA2346567C (fr) | 2005-06-14 |
| AU756441B2 (en) | 2003-01-16 |
| CN1323198A (zh) | 2001-11-21 |
| BR9914532A (pt) | 2001-11-06 |
| EA200100316A1 (ru) | 2002-02-28 |
| AU6096799A (en) | 2000-05-01 |
| DE69907005T2 (de) | 2004-03-18 |
| EP1121100B1 (fr) | 2003-04-16 |
| WO2000021503A1 (fr) | 2000-04-20 |
| HUP0103968A2 (hu) | 2002-04-29 |
| DK1121100T3 (da) | 2003-07-21 |
| ES2197672T3 (es) | 2004-01-01 |
| NO20011673L (no) | 2001-04-03 |
| JP3911125B2 (ja) | 2007-05-09 |
| EP1121100A1 (fr) | 2001-08-08 |
| PL347322A1 (en) | 2002-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4877774A (en) | Administration of steroid hormones | |
| Fenyvesi et al. | Applications of steroid drugs entrapped in cyclodextrins | |
| HU181703B (en) | Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents | |
| EP1978927A1 (de) | Filmförmige arzneiformen zur anwendung in der mundhöhle (wafer) | |
| JPH05504783A (ja) | 水溶解性の高いシクロデキストリン誘導体組成物及びその用途 | |
| JP2004518656A5 (enExample) | ||
| JP2017061465A (ja) | ジエチルスチルベストロール製剤、及び、前立腺又は乳癌の治療におけるその使用 | |
| RU2736245C2 (ru) | Оромукозальные фармацевтические препараты с высокой биодоступностью на основе циклодекстрина и сукралозы | |
| HK1040201A1 (zh) | 包含性激素和環糊精的鼻用噴霧溶液的製備方法 | |
| EP1648386A2 (en) | Transmucosal dosage forms for brain-targeted steroid chemical delivery systems | |
| WO2000037109A2 (en) | Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions | |
| JPS62123196A (ja) | プレドニゾロン包接化合物 | |
| JP2000507258A (ja) | ジクロフェナック／ガンマ―シクロデキストリン包接化合物 | |
| JPH08506831A (ja) | 実質的にアルコールを含有しない医薬組成物の製造方法 | |
| CN100542539C (zh) | 用于紧急糖皮质激素治疗的药物组合物 | |
| Ahmed | Improvement of solubility and dissolution of 19-norprogesterone via inclusion complexation | |
| MXPA01003410A (en) | Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin | |
| CN109381424A (zh) | 稳定的黄体酮水溶注射剂及其制备方法 | |
| TWI283583B (en) | Cyclodextrin-drospirenone inclusion complexes | |
| AU729898B2 (en) | Transdermal therapeutic system having an active compound combination comprising oestriol | |
| HK1126980A (en) | Film-shaped drug forms for use in the oral cavity (wafers) | |
| CN110694075A (zh) | 一种醋酸乌利司他-环糊精包合物的制备方法 | |
| JP2007217318A (ja) | テプレノン製剤及びテプレノン製剤の製造方法 | |
| TW200534866A (en) | Compositions and methods of enhanced transdermal delivery of steroid compounds and preparation methods thereof | |
| JPH09506899A (ja) | 低用量薬剤学的製剤の調製方法 |